Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals conducted a postal ballot through remote e-voting from December 4, 2025 to January 3, 2026, with 23,733 shareholders on record as of November 21, 2025. The single special resolution sought shareholder approval to continue Mr. Jitendra Somchand Shah (DIN: 01609325) as a Non-Executive Independent Director beyond the age of 75 years in his current tenure. Out of 43.79 crore total outstanding shares, only 98.10 lakh shares (2.24%) were polled, with 99.99% voting in favour and just 1,108 shares (0.01%) voting against. The resolution was deemed passed with overwhelming majority, as confirmed by the scrutinizer Mrs. Rupal Patel.
Mr. Jitendra Shah will continue as Non-Executive Independent Director on the board. The voting turnout was very low at 2.24% of outstanding shares, with promoter group votes accounting for nearly all polled shares, suggesting limited retail participation in this routine governance matter.